Jing N - Search Results

1

T40214/PEI complex: a potent therapeutics for prostate cancer that targets STAT3 signaling.

Weerasinghe P, Li Y, Guan Y, Zhang R, Tweardy DJ, Jing N. Weerasinghe P, et al. Among authors: jing n. Prostate. 2008 Sep 15;68(13):1430-42. doi: 10.1002/pros.20807. Prostate. 2008. PMID: 18615483 Free PMC article.

2

Targeting Stat3 in cancer therapy.

Jing N, Tweardy DJ. Jing N, et al. Anticancer Drugs. 2005 Jul;16(6):601-7. doi: 10.1097/00001813-200507000-00002. Anticancer Drugs. 2005. PMID: 15930886 Review.

3

Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer.

Jing N, Zhu Q, Yuan P, Li Y, Mao L, Tweardy DJ. Jing N, et al. Mol Cancer Ther. 2006 Feb;5(2):279-86. doi: 10.1158/1535-7163.MCT-05-0302. Mol Cancer Ther. 2006. PMID: 16505101

4

Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.

Weerasinghe P, Garcia GE, Zhu Q, Yuan P, Feng L, Mao L, Jing N. Weerasinghe P, et al. Among authors: jing n. Int J Oncol. 2007 Jul;31(1):129-36. Int J Oncol. 2007. PMID: 17549413

5

Enhancing or eliminating signals for cell survival to treat disease.

Tweardy DJ, Jing N. Tweardy DJ, et al. Among authors: jing n. Trans Am Clin Climatol Assoc. 2006;117:33-51; discussion 51-2. Trans Am Clin Climatol Assoc. 2006. PMID: 18528463 Free PMC article.

6

G-rich oligonucleotides inhibit HIF-1alpha and HIF-2alpha and block tumor growth.

Guan Y, Reddy KR, Zhu Q, Li Y, Lee K, Weerasinghe P, Prchal J, Semenza GL, Jing N. Guan Y, et al. Among authors: jing n. Mol Ther. 2010 Jan;18(1):188-97. doi: 10.1038/mt.2009.219. Epub 2009 Sep 15. Mol Ther. 2010. PMID: 19755960 Free PMC article.

7

Combined treatment targeting HIF-1α and Stat3 is a potent strategy for prostate cancer therapy.

Reddy KR, Guan Y, Qin G, Zhou Z, Jing N. Reddy KR, et al. Among authors: jing n. Prostate. 2011 Dec;71(16):1796-809. doi: 10.1002/pros.21397. Epub 2011 Apr 7. Prostate. 2011. PMID: 21480310

8

Targeting Stat3 with G-quartet oligodeoxynucleotides in human cancer cells.

Jing N, Li Y, Xu X, Sha W, Li P, Feng L, Tweardy DJ. Jing N, et al. DNA Cell Biol. 2003 Nov;22(11):685-96. doi: 10.1089/104454903770946665. DNA Cell Biol. 2003. PMID: 14659041

9

G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis.

Jing N, Li Y, Xiong W, Sha W, Jing L, Tweardy DJ. Jing N, et al. Among authors: jing l. Cancer Res. 2004 Sep 15;64(18):6603-9. doi: 10.1158/0008-5472.CAN-03-4041. Cancer Res. 2004. PMID: 15374974

10

Rational drug design of G-quartet DNA as anti-cancer agents.

Jing N, Sha W, Li Y, Xiong W, Tweardy DJ. Jing N, et al. Curr Pharm Des. 2005;11(22):2841-54. doi: 10.2174/1381612054546761. Curr Pharm Des. 2005. PMID: 16101441 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters